New Regimen for Elderly Patients With mCRC
Dr. David Kerr reports on a study in which bevacizumab/capecitabine significantly improved PFS in patients at least 70 years old with advanced colorectal cancer.
Source: Medscape Gastroenterology Podcast - Category: Gastroenterology Authors: Medscape Source Type: podcasts
More News: Avastin | Cancer | Cancer & Oncology | Colorectal Cancer | Gastroenterology | Podcasts | Study | Xeloda